Safety and effectiveness of eribulin in Japanese patients with locally advanced or metastatic breast cancer: a post-marketing observational study
Conclusions The safety and effectiveness profile of eribulin was consistent with prior studies. Eribulin had a favorable risk-benefit balance when used in real-world clinical settings.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research
More News: Brain | Breast Cancer | Cancer | Cancer & Oncology | Drugs & Pharmacology | Investigational New Drugs | Japan Health | Neurology | Peripheral Neuropathy | Study